Medical News

RSS

U-M researchers explore prevention measures, treatments for C. difficile infection

Clostridium difficile, a wily, familiar bacterium, causes a growing number of serious infections in U.S. hospitals and nursing homes. With a $7.5 million, five-year award from the National Institutes of Health, University of Michigan researchers plan to discover what factors in the microbe and in patients make C. difficile a formidable, costly problem.

27 Aug 2010

Coalition of organizations request FDA to govern antibiotic usage in food animal production

Today a broad coalition of organizations hand-delivered the U.S. Food and Drug Administration (FDA) more than 180,000 letters responding to the agency's request for comments on rules governing the use of antibiotics on industrial farms.

27 Aug 2010

SU2C, Virgin America enter partnership to raise awareness and funds for cancer research

Stand Up To Cancer (SU2C) and Virgin America, the California-based airline that is reinventing travel, today announce a unique partnership to raise awareness and funds for cancer research. As SU2C's Official Domestic Airline partner, Virgin America (with Virgin Unite) has pledged to support SU2C's mission through a multi-year in-kind travel partnership, Company fundraising and other joint efforts to drive awareness and funding for lifesaving cancer research.

27 Aug 2010

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published today in the journal Thorax.

27 Aug 2010

Vitamin A and beta-carotene supplements unsafe for HIV-positive women

Vitamin A and beta-carotene supplements are unsafe for HIV-positive women who breastfeed because they may boost the excretion of HIV in breast milk---thereby increasing the chances of transmitting the infection to the child, a pair of new studies suggest.

27 Aug 2010

Exposing victimized children to disaster increases emotional, behavioral problems: Study

A new national study not only has confirmed that children who have been exposed to disasters from earthquakes to fires are more prone to emotional problems, but many of those children may already have been experiencing maltreatment, domestic abuse or peer violence that could exacerbate those issues.

27 Aug 2010

Battery of tests for quick assessment of cognitive abilities in Down syndrome patients

Neuroscientists in the Down Syndrome Research Group at the University of Arizona have created a battery of tests that quickly aid in the assessment of the cognitive abilities of persons with Down syndrome.

27 Aug 2010

AgeneBio receives grant to develop neural stabilizer therapy for amnestic mild cognitive impairment

The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.

27 Aug 2010

Surgical robots could be used for teleanesthesia: Study

An existing surgical robot could be used to perform complex regional anesthesia procedures—in theory, allowing expert anesthesiologists to perform robot-assisted procedures from remote locations, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 Aug 2010

NICE suggests bortezomib, thalidomide for multiple myeloma patients

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance which recommends the drugs bortezomib and thalidomide as first-line therapies for some patients with multiple myeloma, a type of cancer that affects cells in the bone marrow.

27 Aug 2010

Lysozyme can protect anthrax contamination in processed foods: Study

An antibacterial enzyme found in human tears and other body fluids could be applied to certain foods for protection against intentional contamination with anthrax, scientists reported here today at the 240th National Meeting of the American Chemical Society (ACS).

27 Aug 2010

Scientist finds man-made chemical enzyme to neutralize toxin

For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables. While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.

27 Aug 2010

New vibration technology to reduce stubborn stomach fat

For millions of dieters it seems impossible to lose belly fat no matter however carefully they watch what they eat or how many sit-ups they do. Some people give up and blame it on genetics, metabolism or body type and simply accept it as a fact of life. For whatever the reason, many Americans discover that stubborn fat around the stomach and love handles will not melt away despite their best efforts. Now a fitness research company says there is an effective way to win the battle of the bulge without special diets, drinks or difficult exercises.

27 Aug 2010

Vanda Pharmaceuticals initiates tasimelteon Phase III clinical trial for Non-24-Hour Sleep Wake Disorder

Vanda Pharmaceuticals Inc., today announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with Non-24-Hour Sleep Wake Disorder (N24HSWD), a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.

26 Aug 2010

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

The Department of Veterans Affairs is partnering with the National Institutes of Health (NIH) to award $6 million in grants for research examining the link between substance abuse and military deployments and combat-related trauma.

26 Aug 2010

Vitamin A may boost HIV excretion in breast milk: Study

Vitamin A and beta-carotene supplements are unsafe for HIV-positive women who breastfeed because they may boost the excretion of HIV in breast milk thereby increasing the chances of transmitting the infection to the child, a pair of new studies suggest.

26 Aug 2010

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.

26 Aug 2010

China PharmaHub signs distribution agreement for radioactive glass sphere treatment for liver cancer

China PharmaHub Corp. ("PharmaHub"), which has recently merged with World Wide Relics which has changed its name to China PharmaHub Corp, and is in the process of obtaining approval from FINRA to trade under its new name with a new symbol, announced today that it has signed an Exclusive Distribution Agreement ("Agreement") with a world leader in precision glass technology which can be utilized to manufacture high precision radioactive glass spheres that emit alpha, beta or gamma radiation, either individually or in combination, for the treatment of malignant tumors of the liver.

26 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

American HomePatient announces extension of self-tender offer

American HomePatient, Inc., one of the nation's largest home health care providers, today announced that it is extending its previously announced self-tender offer for all outstanding shares of common stock of the Company at $0.67 per share, until 5:00 P.M., New York City time, Wednesday, September 1, 2010, unless the tender offer is further extended.

26 Aug 2010

Medical News

U-M researchers explore prevention measures, treatments for C. difficile infection

Coalition of organizations request FDA to govern antibiotic usage in food animal production

SU2C, Virgin America enter partnership to raise awareness and funds for cancer research

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

Vitamin A and beta-carotene supplements unsafe for HIV-positive women

Exposing victimized children to disaster increases emotional, behavioral problems: Study

Battery of tests for quick assessment of cognitive abilities in Down syndrome patients

AgeneBio receives grant to develop neural stabilizer therapy for amnestic mild cognitive impairment

Surgical robots could be used for teleanesthesia: Study

NICE suggests bortezomib, thalidomide for multiple myeloma patients

Lysozyme can protect anthrax contamination in processed foods: Study

Scientist finds man-made chemical enzyme to neutralize toxin

New vibration technology to reduce stubborn stomach fat

Vanda Pharmaceuticals initiates tasimelteon Phase III clinical trial for Non-24-Hour Sleep Wake Disorder

Veterans Affairs partners with NIH to grant award for substance abuse research in military personnel

Vitamin A may boost HIV excretion in breast milk: Study

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

China PharmaHub signs distribution agreement for radioactive glass sphere treatment for liver cancer

Aethlon Medical receives approval for Chronic HCV Infection treatment

American HomePatient announces extension of self-tender offer

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News